The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
Category: Medicare
-
Medicare Will Require Prior Approval for Certain Procedures
A pilot program in six states will use a tactic employed by private insurers that has been heavily criticized for delaying and denying medical care.
-
UnitedHealth Will Cooperate With Federal Probe of Its Medicare Billing Practices
On Thursday, the giant health care conglomerate announced that it had “proactively reached out” to the Justice Department, after reports of a government investigation had surfaced.
-
Trump Administration Will Limit Medicare Spending on Pricey Bandages
In an about-face, the administration is cracking down on so-called skin substitutes, overused treatments that cost Medicare more than $10 billion last year.
-
How to Find the Right Medical Rehab Services
Specialized hospitals, nursing homes, clinics and home health agencies provide rehab therapy. Insurers may limit the services you can get.
-
How to Find the Right Medical Rehab Services
Specialized hospitals, nursing homes, clinics and home health agencies provide rehab therapy. Insurers may limit the services you can get.
-
Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed
For-profit hospitals provide most inpatient physical therapy but tend to have worse readmission rates to general hospitals. Medicare doesn’t tell consumers about troubling inspections.
-
Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed
For-profit hospitals provide most inpatient physical therapy but tend to have worse readmission rates to general hospitals. Medicare doesn’t tell consumers about troubling inspections.
-
Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed
For-profit hospitals provide most inpatient physical therapy but tend to have worse readmission rates to general hospitals. Medicare doesn’t tell consumers about troubling inspections.
-
Drugmakers Notch a $5 Billion Win in Republicans’ Policy Bill
More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings for the federal government.
-
Insurers Pledge to Ease Controversial Prior Approvals for Medical Care
Major companies had faced mounting pressure to stop denying or stalling authorization of coverage for treatments and prescriptions.